Market-leaded Research Development and Innovation Support

Avidin together with partner Synaptogenex awarded with Market-leaded Research Development and Innovation Support


Project title: Development, testing and production of active compounds and functional products for improving memory functions and protecting neuronal cells

Identification number of the project: 2019-1.1.1-PIACI-KFI-2019-00442

Expected duration of the project : 01.01.2020-12.31.2022

Neurological diseases, especially those that appear in older ages (such as dementia, or other, more serious diseases like Alzheimer’s disease) represent great health, social and economical burden. In this project Avidin  aims to develop a food supplement with several effects on elder patients with memory impairment, and also acting as prophylaxis for elderly patients with no memory impairment. We will thoroughly test active agents that are already known and new active agents of natural origin. Avidin will develop combinations of novel agents and already identified active substances (i.e. fungus derived hericenones, erinacines and plant derived bacopasides, natural disaccharides) positively acting on three aspects of neurodegeneration: neuronal death and inflammation, as well as memory. These experiments will not only provide information about the effects of these agents and extracts, but also draw out those which would cause long-term adverse effects. The consortium will execute experimental developments that target the manufacturing of applied research and products.

Parallelly with product development, we will introduce a new system of services for cellular assay modeling of inflammatory mechanism and the death of brain neurons, also suitable for the pharmacological characterization of new and already known active agents of natural origin and new drug candidates.